Rituximab's Effect on Blood Glucose Levels

Main Effects on Glucose Metabolism

Rituximab has no direct effect on blood glucose levels listed as a common adverse effect in clinical guidelines for its use in various conditions including non-Hodgkin's lymphoma, rheumatoid arthritis, and other autoimmune conditions, according to the American College of Chest Physicians 1, 2
Monitoring recommendations for rituximab therapy include CBC, hepatic and renal function, but do not specifically include blood glucose monitoring as a standard requirement, as recommended by the American College of Chest Physicians 1
The primary adverse events associated with rituximab are infusion reactions, infections, and hematologic toxicities rather than metabolic disturbances, as reported by the American College of Chest Physicians 1, 2

When used in Waldenström's macroglobulinemia, rituximab can cause an IgM flare that may lead to hyperviscosity-related complications, but this is not directly related to glucose metabolism, as noted in the medical literature 3, 4

Standard monitoring during rituximab therapy includes CBC, hepatic and renal function tests, but does not specifically include blood glucose monitoring, as recommended by the American College of Chest Physicians 1, 2
For patients with pre-existing diabetes or risk factors for diabetes who are receiving rituximab, routine blood glucose monitoring would be prudent, particularly if they are also receiving concurrent medications that affect glucose metabolism, such as corticosteroids, as suggested by the American College of Chest Physicians 1

For most patients receiving rituximab for standard indications, no special glucose monitoring beyond routine care is required, according to the American College of Chest Physicians 1, 2
In patients with pre-existing diabetes receiving rituximab, standard diabetes monitoring should continue, but no adjustment to diabetes management is typically needed specifically due to rituximab, as recommended by the American College of Chest Physicians 1
When rituximab is used in combination with corticosteroids or other medications known to affect glucose metabolism, the effects on blood glucose should be attributed primarily to those agents rather than to rituximab itself, as noted by the American College of Chest Physicians 1